Kao joins PKO alternative platform
Japan’s Kao Corporation has joined the $120 million venture previously announced by Genomatica and Unilever to scale and commercialise plant-based alternatives to palm kernel oil. The firm described this is as a key move towards meeting goals of becoming carbon-neutral by 2040 carbon-negative by 2050, by making responsibly sourced palm oil and derivatives a critical feedstock.
“Kao’s more than 130 years of expertise in the consumer products and chemical industries deepens the venture’s global reach and impact,” the partners said. Initial research, they claimed, has shown that companies can reduce the carbon footprint of palm-derived ingredients by up to 50% with driven, plant-based alternative.
RELATED ARTICLES
Holiferm has revealed that the Mayor of Wirral, Jeff Green, opened its first commercial biosurfactant plant at Ocean Park in Wallasey, UK, on 16 February.
Croda International has bought Solus Biotech from Korea’s Solus Advanced Materials for about $277 million, subject to regulatory approval.
Symrise has made an unspecified investment to take a minority stake in Israeli biotech Synergio, with the option of owning a majority in future. Financial terms are not being disclosed.
Clariant is to invest CHF 80 million to expand its Care Chemicals facility at Daya Bay in Huizhou, China, by the end of 2024. This will both add capacity for existing products and introduce new products in the pharmaceutical, personal care, home care and industrial sector.
IMCD has agreed agreement to acquire Shanghai Sanrise Industries & Development, a major distributor in China’s personal care markets. This will take place in two tranches: 70% now and the rest in 2025.
Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable fragrance ingredients from renewable carbon, with US-based LanzaTech, which describes itself as a carbon capture and transformation (CCT) company. No commercial terms were disclosed.
